Discover 39 paid clinical trials in Wyoming. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Wyoming provides a wide range of opportunities for both healthy volunteers and those with specific health needs to participate in paid research studies. Active recruitment is underway in major cities like Cheyenne, Casper, and Laramie, granting access to innovative treatments and high-quality medical support.
Filter
1
Filter results
Results: 39
Sustaining Physical Activity After Cancer Exercise Sessions
for
Exercise Oncology, Physical Activity Behavior,
Location: Laramie WY, Fort Collins CO, Aurora CO
Sponsor: Colorado State University
Sex: All
Age: 18+
Code: NCT06359210
Recruiting
Acute Effects of Exercise in College Students With ADHD
Molecular Genetics Studies of Cancer Patients and Their Relatives
for
Malignant Neoplasm
Location: Cheyenne WY, Albuquerque NM, Post Falls ID, Amarillo TX,
Sponsor: City of Hope Medical Center
Sex: All
Age: 0 - 70+
Code: NCT04185935
Recruiting
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGANĀ® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
for
Glaucoma, Open-Angle, Ocular Hypertension
Location: Cheyenne WY, Newport Beach CA, Petaluma CA, Houston TX,
Sponsor: Amneal Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT05401357
Phase3, Recruiting
Navigation and Parent Peer Support to Promote Access
for
Mental Disorder, Child, Mental Health, Family Health
Location: Cheyenne WY, Aurora CO, Pittsburgh PA
Sponsor: University of Colorado, Denver
Sex: All
Age: 1 - 70+
Code: NCT04029220
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Kearney NE, Saint Joseph MO, Osage Beach MO,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Recruiting
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy